Cytosorbents Corp Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31)
Discontinued › Notes
us-gaap:DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage · last filed 2014-08-12
- 2014-06-30: Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) $111.12M.
- 2014-03-31: Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) $107.90M.
- 2013-12-31: Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) $105.81M.
- 2013-09-30: Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) $104.47M.
| Period end | Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) |
|---|---|
| 2014-06-30 | $111.12M 10-Q · filed 2014-08-12 |
| 2014-03-31 | $107.90M 10-Q · filed 2014-05-14 |
| 2013-12-31 | $105.81M 10-Q · filed 2014-08-12 |
| 2013-09-30 | $104.47M 10-Q · filed 2013-11-06 |
| 2013-06-30 | $102.98M 10-Q · filed 2013-08-14 |
| 2013-03-31 | $100.95M 10-Q · filed 2013-05-15 |
| 2012-12-31 | $98.73M 10-K · filed 2014-03-31 |
| 2012-09-30 | $97.55M 10-Q · filed 2012-11-21 |
| 2012-06-30 | $96.27M 10-Q · filed 2012-08-13 |
| 2012-03-31 | $94.65M 10-Q · filed 2012-05-15 |
| 2011-12-31 | $92.56M 10-K · filed 2013-04-03 |
| 2011-09-30 | $90.63M 10-Q · filed 2011-11-14 |
| 2011-06-30 | $88.16M 10-Q · filed 2011-08-15 |
| 2010-12-31 | $83.99M 10-K · filed 2012-03-30 |